Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
Category : Search result: global obesity
Heart Protection from Semaglutide: Key Findings for India
New data shows semaglutide reduces major heart events by 20%, independent of weight loss. This breakthrough offers new hope for India's early-onset heart disease patients. Learn more.
Childhood Hypertension Doubles in UK: A Silent Epidemic
Cases of high blood pressure in UK children have doubled, driven by obesity and poor diet. This 'silent killer' shows no early symptoms but can cause permanent damage. Learn the signs and how parents can act.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Study: High-Fat Diets Give Liver Cancer a Head Start
New research reveals how high-fat diets can trigger molecular changes that promote liver cancer, even before tumors form. Learn how diet impacts your liver health.
Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk
Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.
Hidden Causes of Dog Weight Gain & Breeds Most at Risk
Discover how daily treats and scraps cause dog obesity. Learn which breeds like Pugs & Labradors are prone and how to manage your pet's weight effectively.
2025 Healthcare Review: New Obesity Rules, Alzheimer's Tests, Gene Therapy
A look at 2025's healthcare milestones: new obesity guidelines, Alzheimer's blood tests, gene editing breakthroughs, and India's push for affordable medicines and school sugar boards.
2025: The Year Weight-Loss Drugs Redefined Health in India
Explore how 2025's weight-loss drug boom in India shifted focus from fitness to thinness, raising concerns about medicalisation, side effects, and societal pressure. Read the full analysis.
Ira Khan Opens Up About Obesity, Body Image Struggles
Aamir Khan's daughter Ira Khan candidly discusses her battle with obesity and body image issues since 2020, revealing it feels more exposing than talking about depression. Read her powerful story.
New Study: 75% US Adults May Be Obese, Not 40%
A new study reveals over 75% of US adults may have obesity under new waist-based criteria, nearly double the BMI estimate. Researchers urge updated screening methods.
India's Childhood Obesity Crisis: NFHS Data Shows Alarming Rise
Childhood obesity in India has skyrocketed, with a 288% increase among boys. WHO warns 188 million kids globally will be obese by 2025. Learn the causes, health risks, and prevention strategies.
Doctor: Parents' Food Advice Hurting Millennials' Health
Dr. Mansafa Bepari sparks debate, arguing outdated parental nutrition advice contributes to obesity & diabetes in young Indians. Learn why context matters.
Nutritionist's Rope Test Reveals Hidden Belly Fat Risk
Celebrity nutritionist Pooja Makhija shares a simple rope technique to check waist-to-height ratio, a key indicator of metabolic risk often missed by BMI, especially for Indians.
Friends Influence Your Weight, Says Heart Surgeon
A leading heart surgeon reveals how your social circle impacts your body weight, citing a study that shows a 57% increased obesity risk. Learn how to protect your health.
New 'Fat Switch' Enzyme Discovery Could Fight Obesity
A groundbreaking study reveals the SCoR2 enzyme controls fat storage. Blocking it prevented weight gain & improved cholesterol in animal studies, opening new paths for metabolic health treatments.
India's Weight-Loss Drug Market to Grow 10x by 2030
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
Experts Demand Sugar & Salt Boards in All Karnataka Schools
Following CBSE's mandate for Sugar Boards, experts call for Salt Boards in state schools to combat rising lifestyle diseases among children. Learn why urgent intervention is needed.
Ozempic, Wegovy Reduce Food Spending, New Study Finds
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
New Obesity Drugs Target Cell Energy Production
Scientists develop novel experimental drugs for obesity by targeting mitochondrial energy production in cells, offering a potential new treatment pathway. Learn about this breakthrough research.
Belly Fat Stiffens Heart, Risk Higher for Men: Study
A new German study reveals belly fat silently alters heart structure, raising heart disease risk, especially in men. A cardiologist explains why waist size, not just weight, is critical for Indians.
Teen's liver transplant warns of fatty liver disease risk
A 14-year-old from Surat needed a liver transplant due to advanced fatty liver disease, accelerated by junk food and genetic risk. Hepatologists urge urgent action on childhood obesity and diet.
Sleep, Stress, Belly Fat Drive India's Breast Cancer Surge
ICMR study reveals disrupted sleep, chronic stress, and central obesity are key drivers of India's rising breast cancer burden, projected to add 50,000 cases yearly. Learn the risk factors.
First Weight-Loss Pill Approved in US, Priced $149/Month
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
GLP-1 Drugs Show Benefits Beyond Weight Loss
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
Emcure Enters Obesity Market with Novo Nordisk's Semaglutide
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
Why Stopping Weight-Loss Jabs Feels Like 'Jumping Off a Cliff'
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
Parents Often Overlook Their Child's Weight Issues: Study
A new study from Serbia finds most parents fail to recognise when their child is overweight, delaying crucial health interventions. Learn how to spot the signs and take action for your child's long-term wellbeing.
51% Global Population Overweight by 2035: Report
A new World Obesity Atlas warns 51% of the world will be overweight by 2035. Experts highlight higher cardiovascular risk for Asians at lower BMI. Learn about new drugs and safe weight management.
Page 1 of 4